Toshiba develops 'DNA chip' for interferon efficacy

Toshiba develops 'DNA chip' for interferon efficacy

TOKYO, Japan - Toshiba Corp. said Sept. 19 it has developed the prototype of a compact medical diagnosis equipment (handout photo) to help doctors judge whether interferon treatment is suitable for specific hepatitis C patients by examining individual characteristics of the deoxyribonucleic acid (DNA) of the patients. ''DNA Chip'' enables doctors to speedily decide whether interferon may be administered to a patient despite its side-effects, or if other treatment should be used, Toshiba said.

  • Product Code
  • ILEA001093155
  • Registered date
  • 2002/9/19 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2002 Kyodo News
  • Media size
  • 1864 × 1657 pixel
  • Resolution
  • dpi
  • Deployment size
  • 701.81(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos